NCT07262528 fNIRS Neurofeedback for Post-stroke Hand Rehabilitation
| NCT ID | NCT07262528 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rzeszow |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-12-01 with a primary completion date of 2026-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiovascular diseases are one of the main causes of disability. Among post-stroke individuals, 80% experience upper limb dysfunction, while only 5% to 20% of individuals regain full limb and hand function. The purpose of this study is to evaluate the effects of hand rehabilitation of post-stroke individuals using HEG Neurofeedback The study will include 30 participants in the early sub-acute phase post-stroke, who will be assigned to either the study group or the control group. Participants in the experimental group will follow a rehabilitation program extended with HEG Neurofeedback training, while participants in the control group will follow the standard rehabilitation program. The HEG Neurofeedback therapy equipment will be supplemented with new hand therapy software. During the exercises, patients will focus on a discussed and presented task, and once the expected level of concentration is reached, the software will trigger a virtual hand performing a finger flexion movement. Motor control of the hand will be assessed using the Fugl-Meyer Scale and Brunnström recovery stages.
Eligibility Criteria
Inclusion Criteria: * individuals with hemiparesis after a first ischemic stroke, * subacute stroke period (no longer than 3 months), * upper limb paresis rated 2-4 by Brunnstrom recovery stages, * participants aged 18 to 70 years, * consent to participate in the study. Exclusion Criteria: * unstable general condition, * visual field disorders, * inability to sit independently, * cognitive impairment (Mini-Mental State Examination, MMSE \> 24).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07262528 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07262528 currently recruiting?
Yes, NCT07262528 is actively recruiting participants. Contact the research team at aguzik@ur.edu.pl for enrollment information.
Where is the NCT07262528 trial being conducted?
This trial is being conducted at Rzeszów, Poland.
Who is sponsoring the NCT07262528 clinical trial?
NCT07262528 is sponsored by University of Rzeszow. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.